Autor: |
Ardeshir Ghavamzadeh, Kamran Alimoghaddam, Seyyedasadollah Mousavi, Babak Bahar, Masoud Iravani, Amir Hamdi, Fatemeh Ghaffari, Arash Jalali, Mohammad Jahani |
Jazyk: |
angličtina |
Rok vydání: |
2011 |
Předmět: |
|
Zdroj: |
International Journal of Hematology-Oncology and Stem Cell Research, Vol 5, Iss 4 (2011) |
Druh dokumentu: |
article |
ISSN: |
2008-2207 |
Popis: |
Post-remission treatment in patients with acute myeloid leukemia is still controversial. One potent choice for patients with no donor available is autologous stem cell transplantation. The median follow-up period was 18 months and the median age was 26 years old. In the review of 116 recently diagnosed AML patients (except AML- M3) who underwent autologous stem cell transplantation, 72.4% of patients remained alive and 27.6% relapsed. Relapse was the most common causes of death in patients. The one- year OS and DFS of patients was 73.8% and 59.8%, respectively. There was no statistically significant difference between age, sexuality and waiting time from diagnosis to transplantation. For more comprehensive results, longer follow- up is required. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|